Combined Monocyte Chemoattractant Protein-1 and High-Sensitivity C-Reactive Protein Predict Mortality Rates in the General Population ― Evidence From a Community-Based Cohort in Japan ―
Circulation Journal · 2026
DOI: 10.1253/circj.cj-25-0884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Journal, 2026. Verfasst von Yume Nohara-Shitama und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardio-Vascular Medicine, Department of Internal Medicine, Kurume University School of Medicine. Hauptthemen laut MEDLINE: C-Reactive Protein, Chemokine CCL2, Neoplasms, Cardiovascular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Kimura Memorial Heart Foundation, Lotte Research Promotion Grant, Kurume University Ishibashi Foundation.
Abstract (Originalsprache)
BACKGROUND: Because monocyte chemoattractant protein-1 (MCP-1) and high-sensitivity C-reactive protein (hs-CRP) are crucial biomarkers in the early stages of atherosclerosis, we examined the association of their serum levels with all-cause and cause-specific deaths in a healthy population. METHODS AND RESULTS: Between 2004 and 2007, 568 participants (64% women, mean age 64.4 years) underwent health check-ups from which their serum MCP-1 and hs-CRP levels were categorized as high or low based on the median values of each biomarker. We analyzed all-cause deaths using Kaplan-Meier curves and used a multivariable Cox regression model to calculate hazard ratios for all-cause, cardiovascular disease (CVD), and cancer deaths both individually and in combination. During a median follow-up of 17.9 years, 140 deaths occurred: 43 from CVD and stroke, and 33 from cancer. The cumulative all-cause mortality rate was higher in participants with both high serum MCP-1 and hs-CRP levels than in those with lower levels. The adjusted hazard ratios for combined high serum MCP-1 and hs-CRP levels vs. low levels were 1.86 (95% confidence interval (CI): 1.09-3.17) for all-cause, 3.24 (95% CI: 1.07-9.82) for CVD and stroke, and 3.28 (95% CI: 1.06-10.18) for cancer deaths. CONCLUSIONS: Combined serum MCP-1 and hs-CRP levels could predict all-cause and cause-specific mortality rates in the general population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardio-Vascular Medicine, Department of Internal Medicine, Kurume University School of Medicine.
- Keikokai, Hara Hospital.
- Department of Community Medicine, Kurume University School of Medicine.
- Department of Sports Medicine and Science, Faculty of Human Health, Kurume University.
Förderung
- Kimura Memorial Heart Foundation
- Lotte Research Promotion Grant
- Kurume University Ishibashi Foundation
Zitieren
APA
Nohara-Shitama, Y., Adachi, H., Shimoyama, M., Takubo, H., Sato, H., Morikawa, N., Fukami, A., Enomoto, M., & Fukumoto, Y. (2026). Combined Monocyte Chemoattractant Protein-1 and High-Sensitivity C-Reactive Protein Predict Mortality Rates in the General Population ― Evidence From a Community-Based Cohort in Japan ―. Circulation Journal. https://doi.org/10.1253/circj.cj-25-0884
Vancouver
Nohara-Shitama Y, Adachi H, Shimoyama M, Takubo H, Sato H, Morikawa N, et al. Combined Monocyte Chemoattractant Protein-1 and High-Sensitivity C-Reactive Protein Predict Mortality Rates in the General Population ― Evidence From a Community-Based Cohort in Japan ―. Circulation Journal. 2026. doi:10.1253/circj.cj-25-0884
BibTeX
@article{NoharaShitama2026,
author = {Nohara-Shitama, Yume and Adachi, Hisashi and Shimoyama, Mayo and Takubo, Harumi and Sato, Hiromi and Morikawa, Nagisa and Fukami, Ako and Enomoto, Mika and Fukumoto, Yoshihiro},
title = {Combined Monocyte Chemoattractant Protein-1 and High-Sensitivity C-Reactive Protein Predict Mortality Rates in the General Population ― Evidence From a Community-Based Cohort in Japan ―},
journal = {Circulation Journal},
year = {2026},
doi = {10.1253/circj.cj-25-0884}
}
EUVIMED